Skip to main content
. 2014 Oct 8;29(10):1360–1366. doi: 10.3346/jkms.2014.29.10.1360

Table 1.

Baseline and pathologic characteristics of 205 patients with hepatocellular carcinoma who underwent living donor liver transplantation

graphic file with name jkms-29-1360-i001.jpg

AFP, alpha-fetoprotein; HBV, hepatitis B; HCV, hepatitis C; MELD, model for end-stage liver disease; TACE, transarterial chemoembolization.